After 30 Years, a ' Home Run ' for Treating Rhabdomyosarcoma? After 30 Years, a ' Home Run ' for Treating Rhabdomyosarcoma?

Low-dose maintenance chemotherapy given after standard intensive chemotherapy improves both disease-free survival and overall survival in children with rhabdomyosarcoma. Are these new data paradigm changing?Medscape Medical News

Source: Medscape Medical News Headlines - June 4, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news